DealsHealth
01 June 2023, 5:42 pm 1 minute
Reuters has exclusively seen documents indicating Swiss drugmaker Roche Holding AG (ROG.S) plans to sell its 800-employee drug manufacturing plant in Vacaville, California, or it will shut the factory by 2029.
Market Impact
Roche is under pressure to develop new treatments to offset the loss of billions in sales due to cheap biotech copies of its established cancer medicines Herceptin, Avastin and Rituxan.
Article Tags
Topics of Interest: DealsHealth
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Americas
Countries: SwitzerlandUnited States
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Significant National Story
Credit:
1: https://www.reutersagency.com/en/reutersbest/article/roche-looking-to-sell-or-shut-down-california-biologic-drug-plant/
The Mention Sources Can Contact is to remove/Changing this articles